echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > EHJ Chinese scholars: PCI and CABG in patients with diabetes and coronary heart disease have the same efficacy and mortality rate!

    EHJ Chinese scholars: PCI and CABG in patients with diabetes and coronary heart disease have the same efficacy and mortality rate!

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cardiovascular disease (CVD) is the leading comorbidity of diabetes


    Vascular Diabetes Diabetes is associated with worse outcomes after coronary revascularization and was identified as an independent predictor of adverse events in CVD patients


    Myocardial infarction , PCI resulted in a higher 5-year rate of MACCE (major adverse cardiovascular and cerebrovascular events: a composite of all-cause death, cerebrovascular accident, MI or repeat revascularization) rate compared with CABG due to a high rate of repeated revascularization


    The SYNTAXES study evaluated 10-year survival in 1800 patients with three-vessel disease (3VD) and/or left main coronary artery disease (LMCAD) who were randomized to PCI or CABG in the SYNTAX trial


    Among diabetic patients (n = 452), PCI was associated with a higher risk of death at 5 years compared with CABG [19.


    Among diabetic patients (n = 452), PCI was associated with a higher risk of death at 5 years compared with CABG [19.


    In insulin-treated patients (n = 182), all-cause death after 10 years was numerically higher than in PCI (47.


    Effects of PCI and CABG on 10-year all-cause mortality in 3VD/LMCAD patients with drug-treated diabetes and insulin-treated diabetes


    Effects of PCI and CABG on 10-year all-cause mortality in 3VD/LMCAD patients with drug-treated diabetes and insulin-treated diabetes


    In conclusion, in patients with 3VD and/or LMCAD, regardless of the presence of diabetes, PCI and CABG were similar in the treatment of all-cause mortality within 10 years


    references:

    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease , European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 56–67, https://doi.


    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery diseaseLeave

    a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.